Skip to content

Investigating the effect of herbal medicineTrachyspermumammi L on the symptoms of gastro-oesophageal reflux

Comparison of the effect of the hydroalcoholic extract of the medicinal plant Xenian (Trachyspermumammi L.), omeprazole and their simultaneous use on the symptoms and quality of life related to the health of patients with gastro-oesophageal reflux.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220619055216N1
Enrollment
120
Registered
2022-11-13
Start date
2022-10-23
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with gastroesophageal reflux. Gastro-esophageal reflux disease

Interventions

Intervention 1: Intervention group 1: Zenian essential oil capsules 150 mg: They use it once a day for 4 weeks. Zenian essential oil is produced in Kashan essential oil Barich pharmaceutical company.

Sponsors

Yasouj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Being 18-60 years old Consent to participate in the study and sign the informed consent form Diagnosing gastroesophageal reflux by gastroenterologist based on ROME lll criteria Body mass index (BMI) less than 30 (BMI>30) Absence of systemic diseases Absence of neurological defects

Exclusion criteria

Exclusion criteria: Taking antibiotics or non-steroidal anti-inflammatory drugs 2 weeks before the study Previous participation in studies similar to the current research Drug or alcohol abuse Existence of gastrointestinal malignancy based on history, physical examination, laboratory tests (for example, the number of white blood cells, CRP, ESR, and upper endoscopy) Liver and kidney function disorders based on laboratory tests Pregnancy History of severe allergy to medicinal plants History of upper gastrointestinal surgery and serious diseases such as heart failure, diabetes, epilepsy, previous or current significant psychiatric disorders

Design outcomes

Primary

MeasureTime frame
Reflux Symptom Index. Timepoint: Before and after the intervention. Method of measurement: reflux symptom index questionnaire.;Health-related quality of life - gastroesophageal reflux disease (GERD-HRQL. Timepoint: Before and after the intervention. Method of measurement: Health-related quality of life - gastroesophageal reflux disease (GERD-HRQL).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhsan Elahinia

Yasouj University of Medical Sciences

elahie@93gmail.com+98 74 3322 7573

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026